Carolina Vásquez Narváez
Research Subjects
Carolina Vásquez Narváez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Andrés López-Cortés
Cancer Research Group (CRG), Faculty of Medicine, Universidad de las Américas
1 shared publication - Esteban Ortiz-Prado
One Health Research Group, Universidad de Las Américas, Quito, Ecuador
1 shared publication - Humberto Alejandro Nati Castillo
School of Health Sciences, Universidad CES, Medellin 050021, Colombia
1 shared publication - Janeth C. Gil
Facultad de Salud, Universidad Santiago de Cali, Cali 760033, Colombia
1 shared publication - Jhan Sebastian Saavedra Torres
Facultad de Ciencias de la Salud, Fundación Universitaria Vision de las Americas, Pereira 660003, Colombia
1 shared publication - Juan Jose Martinez Penaranda
Interinstitutional Internal Medicine Group (GIMI 1), Universidad Libre, Cali 760032, Colombia
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 46 (2) , 179-186
Accidente cerebrovascular isquémico en un paciente VIH: neurosífilis y síndrome antifosfolípidos
La infección por HIV es un factor de riesgo para el desarrollo de enfermedades cardiovasculares, incluyendo los accidentes cerebrovasculares isquémicos.Se presenta el caso de un hombre de 27 años con sida, con un accidente cerebrovascular isquémico de la arteria cerebral media izquierda. Los exámenes de laboratorio confirmaron el diagnóstico de neurosífilis y, además, confirmaron la existencia de anticuerpos antifosfolípidos. Siete meses después del tratamiento de la neurosífilis, de la anticoagulación y de la terapia antirretroviral, se confirmó la persistencia de anticuerpos antifosfolípidos.El enfoque diagnóstico de un accidente cerebral vascular en personas con HIV es un reto, ya que puede asociarse a múltiples etiologías. La relevancia de los anticuerpos antifosfolípidos en estos pacientes es tema de debate y debe tenerse en cuenta según el cuadro clínico.
- 1 June 2026
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 46 (2) , 179-186
Open AccessAccidente cerebrovascular isquémico en un paciente VIH: neurosífilis y síndrome antifosfolípidos
La infección por HIV es un factor de riesgo para el desarrollo de enfermedades cardiovasculares, incluyendo los accidentes cerebrovasculares isquémicos.Se presenta el caso de un hombre de 27 años con sida, con un accidente cerebrovascular isquémico de la arteria cerebral media izquierda. Los exámenes de laboratorio confirmaron el diagnóstico de neurosífilis y, además, confirmaron la existencia de anticuerpos antifosfolípidos. Siete meses después del tratamiento de la neurosífilis, de la anticoagulación y de la terapia antirretroviral, se confirmó la persistencia de anticuerpos antifosfolípidos.El enfoque diagnóstico de un accidente cerebral vascular en personas con HIV es un reto, ya que puede asociarse a múltiples etiologías. La relevancia de los anticuerpos antifosfolípidos en estos pacientes es tema de debate y debe tenerse en cuenta según el cuadro clínico.
- Open Access
Reframing West Nile Virus in Latin America: From Enzootic Evidence to Human Risk—Surveillance Gaps and One Health Actions
West Nile virus (WNV) is a mosquito-borne flavivirus with one of the widest global distributions. Since its discovery in Uganda in 1937, it has become a major zoonotic pathogen, and after its introduction into the United States in 1999, it spread rapidly across the Americas, becoming the leading cause of neuroinvasive arboviral disease. Its expansion illustrates a remarkable ecological adaptability, further intensified by climate change. In Latin America and the Caribbean, WNV circulation has been consistently documented in birds, horses, and mosquitoes; however, confirmed human cases remain disproportionately scarce compared with North America and Europe. Reports include sporadic human cases in Brazil (>100 since 2014), Mexico (~13), Argentina (2006–2007), Puerto Rico (2007), Nicaragua, and Haiti, while animal and vector evidence extends to Guatemala, El Salvador, Belize, Costa Rica, Bolivia, Paraguay, Colombia, Venezuela, Cuba, and Ecuador. This paradox likely reflects structural limitations within regional health systems, including underdiagnosis, restricted diagnostic capacity, and significant surveillance gaps, particularly in contexts where mild febrile syndromes may be misclassified as dengue, Zika, or Chikungunya. The regional risk of emergence is further amplified by climatic variability, ecological change, and intensifying human–wildlife interactions. Experiences from Europe highlight the importance of early detection, transfusion safety, and integrated surveillance within a One Health framework. Strengthening preparedness in Latin America will require investments in diagnostic infrastructure, implementation of standardized seroepidemiological surveys, development of predictive models tailored to local ecological contexts, and robust intersectoral collaboration.
Open AccessReframing West Nile Virus in Latin America: From Enzootic Evidence to Human Risk—Surveillance Gaps and One Health Actions
West Nile virus (WNV) is a mosquito-borne flavivirus with one of the widest global distributions. Since its discovery in Uganda in 1937, it has become a major zoonotic pathogen, and after its introduction into the United States in 1999, it spread rapidly across the Americas, becoming the leading cause of neuroinvasive arboviral disease. Its expansion illustrates a remarkable ecological adaptability, further intensified by climate change. In Latin America and the Caribbean, WNV circulation has been consistently documented in birds, horses, and mosquitoes; however, confirmed human cases remain disproportionately scarce compared with North America and Europe. Reports include sporadic human cases in Brazil (>100 since 2014), Mexico (~13), Argentina (2006–2007), Puerto Rico (2007), Nicaragua, and Haiti, while animal and vector evidence extends to Guatemala, El Salvador, Belize, Costa Rica, Bolivia, Paraguay, Colombia, Venezuela, Cuba, and Ecuador. This paradox likely reflects structural limitations within regional health systems, including underdiagnosis, restricted diagnostic capacity, and significant surveillance gaps, particularly in contexts where mild febrile syndromes may be misclassified as dengue, Zika, or Chikungunya. The regional risk of emergence is further amplified by climatic variability, ecological change, and intensifying human–wildlife interactions. Experiences from Europe highlight the importance of early detection, transfusion safety, and integrated surveillance within a One Health framework. Strengthening preparedness in Latin America will require investments in diagnostic infrastructure, implementation of standardized seroepidemiological surveys, development of predictive models tailored to local ecological contexts, and robust intersectoral collaboration.